Clinical Trial Update: To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety and effectiveness of a granisetron transdermal patch for chemotherapy-induced nausea and vomiting has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Granisetron transdermal patch (granisetron)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 3 | Status: COMPLETED